SpyGlass Pharma, Inc. Common Stock ( SGP) - Key Metrics
SGP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.59 | -$0.44 | -$0.50 |
| 2026Q1 | $0 | -$0.69 | -$0.68 | -$0.71 |
| 2025Q4 | $0 | -$0.38 | -$0.28 | -$0.29 |
| 2025Q3 | $0 | -$0.29 | -$0.26 | -$0.27 |
SGP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.43 |
| 2026Q1 | 0% | -9.39 |
| 2025Q4 | 0% | -17.37 |
| 2025Q3 | 0% | -22.48 |
SGP
Price: $26.23
52 week price:
Earnings Per Share: -1.67 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 864.3 million